How do parkinsonian signs return after discontinuation of subthalamic DBS?

被引:329
作者
Temperli, P
Ghika, J
Villemure, JG
Burkhard, PR
Bogousslavsky, J
Vingerhoets, FJG [1 ]
机构
[1] CHU Vaudois, Neurol Serv BH 13, Dept Neurol, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Dept Neurosurg, CH-1011 Lausanne, Switzerland
[3] Geneva HUG, Dept Neurol, Geneva, Switzerland
关键词
D O I
10.1212/WNL.60.1.78
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To study the reappearance of the clinical signs of PD when subthalamic nucleus (STN) deep brain stimulation (DBS) was turned off. Method: The authors studied 35 patients treated with STN DBS 6.7 +/- 3.3 months (mean +/- SD) after implantation. All were clinically improved. Twenty-four had not required any antiparkinsonian medication for many months and 11 were in "practically defined off" conditions when studied. Unified Parkinson's Disease Rating Scale (UPDRS) motor scores were assessed at baseline and 5, 15, 30, 60, 90, 120, 150, 180, and 240 minutes after switching off STN DBS. Results: A sequential pattern of return of parkinsonian signs was observed, with a fast worsening of tremor within minutes, followed by a smoother, slower worsening of bradykinesia and rigidity over half an hour to an hour, and finally a slow and steady worsening of axial signs over 3 to 4 hours. Ninety percent of the UPDRS motor score worsening was reached after 2 hours. When switching STN DBS "on" again, all motor UPDRS subscores improved with a similar pattern, but faster than their rate of worsening, especially for axial signs. Conclusions: STN DBS may act by different mechanisms on the four major parkinsonian signs. At least 3 hours off STN DBS is needed to estimate the clinical effect of stimulation.
引用
收藏
页码:78 / 81
页数:4
相关论文
共 28 条
  • [1] The long-duration action of levodopa may be due to a postsynaptic effect
    Barbato, L
    Stocchi, F
    Monge, A
    Vacca, L
    Ruggieri, S
    Nordera, G
    Marsden, CD
    [J]. CLINICAL NEUROPHARMACOLOGY, 1997, 20 (05) : 394 - 401
  • [2] Bejjani BP, 2000, ANN NEUROL, V47, P655, DOI 10.1002/1531-8249(200005)47:5<655::AID-ANA16>3.0.CO
  • [3] 2-#
  • [4] Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO
  • [5] 2-C
  • [6] Fahn S., RECENT DEV PARKINSON, V2, P153, DOI DOI 10.1002/ANA.410220556
  • [7] Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review
    Ghika, J
    Villemure, JG
    Fankhauser, H
    Favre, J
    Assal, G
    Ghika-Schmid, F
    [J]. JOURNAL OF NEUROSURGERY, 1998, 89 (05) : 713 - 718
  • [8] Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
    Krack, P
    Pollak, P
    Limousin, P
    Hoffmann, D
    Xie, J
    Benazzouz, A
    Benabid, AL
    [J]. BRAIN, 1998, 121 : 451 - 457
  • [9] Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation
    Krack, P
    Benazzouz, A
    Pollak, P
    Limousin, P
    Piallat, B
    Hoffmann, D
    Xie, J
    Benabid, AL
    [J]. MOVEMENT DISORDERS, 1998, 13 (06) : 907 - 914
  • [10] Krack P, 2000, J NEUROL, V247, P122